MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/qai.0000000000001842

Медицинская библиотека · Journal of acquired immune deficiency syndromes (1999) · 2018

Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.

Grover Surbhi, Desir Fidel, Jing Yuezhou, Bhatia Rohini K, Trifiletti Daniel M, Swisher-McClure Samuel, Kobie Julie, Moore Richard D, Rabkin Charles S, Silverberg Michael J, Salters Kate, Mathews William Christopher, Gill Michael John, Thorne Jennifer E, Castilho Jessica, Kitahata Mari M, Justice Amy, Horberg Michael A, Achenbach Chad J, Mayor Angel M, Althoff Keri N, North American AIDS Cohort Collaboration on Research and Design

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАПоддержка службы здравоохранения СШАПеревод в очереди

Аннотация

BACKGROUND

It is not known whether immune dysfunction is associated with increased risk of death after cancer diagnosis in persons with HIV (PWH). AIDS-defining illness (ADI) can signal significant immunosuppression. Our objective was to determine differences in cancer stage and mortality rates in PWH with and without history of ADI.

METHODS

PWH with anal, oropharynx, cervical, lung cancers, or Hodgkin lymphoma diagnoses from January 2000 to December 2009 in the North American AIDS Cohort Collaboration on Research and Design were included.

RESULTS

Among 81,865 PWH, 814 had diagnoses included in the study; 341 (39%) had a history of ADI at time of cancer diagnosis. For each cancer type, stage at diagnosis did not differ by ADI (P > 0.05). Mortality and survival estimates for cervical cancer were limited by n = 5 diagnoses. Adjusted mortality rate ratios showed a 30%-70% increase in mortality among those with ADI for all cancer diagnoses, although only lung cancer was statistically significant. Survival after lung cancer diagnosis was poorer in PWH with ADI vs. without (P = 0.0001); the probability of survival was also poorer in those with ADI at, or before other cancers although not statistically significant.

CONCLUSIONS

PWH with a history of ADI at lung cancer diagnosis had higher mortality and poorer survival after diagnosis compared to those without. Although not statistically significant, the findings of increased mortality and decreased survival among those with ADI (vs. without) were consistent for all other cancers, suggesting the need for further investigations into the role of HIV-related immune suppression and cancer outcomes.

Для цитирования: Grover Surbhi, Desir Fidel, Jing Yuezhou, Bhatia Rohini K, Trifiletti Daniel M, Swisher-McClure Samuel, Kobie Julie, Moore Richard D, Rabkin Charles S, Silverberg Michael J, Salters Kate, Mathews William Christopher, Gill Michael John, Thorne Jennifer E, Castilho Jessica, Kitahata Mari M, Justice Amy, Horberg Michael A, Achenbach Chad J, Mayor Angel M, Althoff Keri N, North American AIDS Cohort Collaboration on Research and Design. Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis.. Journal of acquired immune deficiency syndromes (1999). 2018. DOI: 10.1097/qai.0000000000001842.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.